The Effects of 1-Year Treatment With a Herbst Mandibular Advancement Splint on Obstructive Sleep Apnea, Oxidative Stress, and Endothelial Function
The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Background Obstructive sleep apnea (OSA) is associated with endothelial dysfunction. In the current study, we assessed the effect of long-term modified Herbst mandibular advancement splint (MAS) treatment on OSA, oxidative stress markers, and on endothelial function (EF). Methods A total of 16 subjects participated (11 men and 5 women; mean [+/- SD] age, 54.0 +/- 8.3 years; mean body mass index, 28.0 +/- 3.1 kg/m(2)), 12 of whom completed the 1-year evaluation. Apnea severity, levels of oxidative stress markers, and EF were assessed after 3 months and 1 year of receiving treatment. For comparison, 6 untreated patients underwent two evaluations 9 months apart, and 10 non-OSA individuals were assessed once as a reference group. The results are presented as the mean +/- SD. Results The mean apnea-hypopnea index (AHI) decreased significantly from 29.7 +/- 18.5 events/h before treatment to 17.7 +/- 11.1 events/h after 3 months of treatment and 19.6 +/- 11.5 events/h after 1 year of treatment (p Conclusions The Herbst MAS may be a moderately effective long-term treatment for patients with OSA. EF improved to levels that were not significantly different than reference levels, even though apneic events were not completely eliminated. We think that these data are encouraging and that they justify the performance of larger randomized controlled studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Promising effects on blood pressure, cardiac function, endothelial function, markers of oxidative stress and simulated driving performance have been reported from MADs 66, 69, 84, 94–99.”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [96]
Citations
Cites
[30] Microsomal lipid peroxidation
Buege, J. A., & Aust, S. D. (1978) · Methods in Enzymology · doi:10.1016/s0076-6879(78)52032-6 · Cited by 13,343
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,654
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71141-7 · Cited by 4,678
Nieto, F. J. (2000) · JAMA · doi:10.1001/jama.283.14.1829 · Cited by 3,369
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
Shamsuzzaman, A. S. M., Gersh, B. J., & Somers, V. K. (2003) · JAMA · doi:10.1001/jama.290.14.1906 · Cited by 1,188
Pepperell, J. C., Ramdassingh-Dow, S., Crosthwaite, N., Mullins, R., Jenkinson, C., Stradling, J. R., & Davies, R. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07445-7 · Cited by 1,052
Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study
Lavie, P. (2000) · BMJ · doi:10.1136/bmj.320.7233.479 · Cited by 1,021
Self-citation
Cited by
Adult obstructive sleep apnoea
Jordan, A. S., McSharry, D. G., & Malhotra, A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60734-5 · Cited by 1,735
Obstructive sleep apnoea syndrome
Lévy, P., Kohler, M., McNicholas, W. T., Barbé, F., McEvoy, R. D., Somers, V. K., Lavie, L., & Pépin, J.-L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.15 · Cited by 1,235
Self-citationLavie, L. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.07.003 · Cited by 681
Self-citationMechanisms of vascular damage in obstructive sleep apnea
Kohler, M., & Stradling, J. R. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.145 · Cited by 513
Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More
Gozal, D., & Kheirandish-Gozal, L. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1190pp · Cited by 399
Non-CPAP therapies in obstructive sleep apnoea
Randerath, W. J., Verbraecken, J., Andreas, S., Bettega, G., Boudewyns, A., Hamans, E., Jalbert, F., Paoli, J. R., Sanner, B., Smith, I., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00099710 · Cited by 388
Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link
Lavie, L., & Lavie, P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00086608 · Cited by 369
Self-citationOxidative Stress—A Unifying Paradigm in Obstructive Sleep Apnea and Comorbidities
Lavie, L. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.08.003 · Cited by 266
Self-citationNon-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy
Marklund, M., Verbraecken, J., & Randerath, W. (2012) · European Respiratory Journal · doi:10.1183/09031936.00144711 · Cited by 239
Cardiovascular Complications of Obstructive Sleep Apnea Syndrome: Evidence from Children
Bhattacharjee, R., Kheirandish-Gozal, L., Pillar, G., & Gozal, D. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.03.002 · Cited by 206
Self-citationAnandam, A., Patil, M., Akinnusi, M., Jaoude, P., & El‐Solh, A. A. (2013) · Respirology · doi:10.1111/resp.12140 · Cited by 189
Assessment of Endothelial Function Using Digital Pulse Amplitude Tonometry
Hamburg, N. M., & Benjamin, E. J. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.03.001 · Cited by 177
“…including L-arginine infusion, sildenafil, air filtration to reduce particulate matter, treatment of malaria, and therapy for 9 obstructive sleep apnea, all similarly enhanced the PAT hyperemic response (Aversa et al. 2008, Brauner et al. 2008, Itzhaki et al. 2007, Yeo et al. 2007, 2008).”
MethodInflammation, Oxidative Stress, and the Vascular Endothelium in Obstructive Sleep Apnea
Jelic, S., & Le Jemtel, T. H. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.11.008 · Cited by 163
“BMI, and cardiovascular comorbidities after 1 year of suboptimal therapy with an oral device (mean residual AHI 19/h, which equals persistent moderate OSA) (Itzhaki et al. 2007).”
BackgroundEndothelial Function in Obstructive Sleep Apnea
Atkeson, A., Yeh, S. Y., Malhotra, A., & Jelic, S. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.08.002 · Cited by 150
Obstructive Sleep Apnea Syndrome and Cardiovascular Diseases
Fava, C., Montagnana, M., Favaloro, E., Guidi, G., & Lippi, G. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1273092 · Cited by 148
Trzepizur, W., Gagnadoux, F., Abraham, P., Rousseau, P., Meslier, N., Saumet, J.-L., & Racineux, J.-L. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2008.06.013 · Cited by 144
“[22] demonstrated an improvement in endothelial functioning after 3 months of treatment with modified”
BackgroundTrazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold
Smales, E. T., Edwards, B. A., Deyoung, P. N., McSharry, D. G., Wellman, A., Velasquez, A., Owens, R., Orr, J. E., & Malhotra, A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201408-399oc · Cited by 127
McCrea, C. E., Skulas-Ray, A. C., Chow, M., & West, S. G. (2012) · Vascular Medicine · doi:10.1177/1358863x11433188 · Cited by 123
Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus
Greenberg, H., & Rajan, P. (2015) · Nature and Science of Sleep · doi:10.2147/nss.s90835 · Cited by 120
Serra‐Torres, S., Bellot‐Arcís, C., Marco‐Algarra, J., & Almerich‐Silla, J. M. (2015) · The Laryngoscope · doi:10.1002/lary.25505 · Cited by 134
Oral appliance treatment of obstructive sleep apnea: an update
Chan, A. S., & Cistulli, P. A. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283319b12 · Cited by 103
Treating OSA : C urrent and emerging therapies beyond CPAP
Lorenzi‐Filho, G., Almeida, F. R., & Strollo, P. J. (2017) · Respirology · doi:10.1111/resp.13144 · Cited by 116
Zhang, W., & Si, L. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.707253 · Cited by 117
Mandibular advancement device and CPAP upon cardiovascular parameters in OSA
Fabbro, C. D., Garbuio, S. A., D’Almeida, V., Cintra, F. D., Tufik, S. B., & Bittencourt, L. (2014) · Sleep And Breathing · doi:10.1007/s11325-014-0937-5 · Cited by 102
“These parameters were chosen based on previous literature with OSA patients after treatments such as MAD and CPAP [9, 10, 32].”
BackgroundMethodResultInfluentialVatansever, E., Sürmen-Gür, E., Ursavaş, A., & Karadağ, M. (2010) · Sleep And Breathing · doi:10.1007/s11325-010-0378-8 · Cited by 95
“reported negative results, most have shown oxidative stress to be associated with OSA [30–32].”
ResultScherr, S. C., Dort, L. C., Almeida, F. R., Bennett, K. M., Blumenstock, N. T., Demko, B. G., Essick, G., Katz, S. G., McLornan, P. M., Phillips, K. S., et al. (2014) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.3738 · Cited by 97
Mouth breathing: adverse effects on facial growth, health, academics, and behavior.
Jefferson, Y. (2010) · PubMed · Cited by 161
Mesarwi, O. A., Sharma, E. V., Jun, J. C., & Polotsky, V. Y. (2015) · Sleep and Biological Rhythms · doi:10.1111/sbr.12078 · Cited by 80
Iwasaki, T., Takemoto, Y., Inada, E., Sato, H., Saitoh, I., Kakuno, E., Kanomi, R., & Yamasaki, Y. (2014) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2014.08.017 · Cited by 96
Lavie, L., & Polotsky, V. (2009) · Respiration · doi:10.1159/000243552 · Cited by 78
Self-citationEndothelial Dysfunction in Adults with Obstructive Sleep Apnea
(2011) · Advances in cardiology · doi:10.1159/000325108 · Cited by 82
Autonomic alterations and endothelial dysfunction in pediatric obstructive sleep apnea
Gozal, D., Bhattacharjee, R., & Gozal, D. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.12.013 · Cited by 80
“Similar findings were also communicated in younger adult patients with OSAS who were free of any known cardiovascular involvement, and, as previously shown, CPAP treatment resulted in reversal of endothelial dysfunction [84,85].”
ResultPeled, N., Shitrit, D., Fox, B. D., SHLOMI, D., Amital, A., Bendayan, D., & Kramer, M. R. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081088 · Cited by 75
“184 I, n (%) 13 7 (24) 1 (10) 8 II, n (%) 17 (61) 6 (61) III-IV, n (%) 4 (14) 3 (30) Clinical findings Pulse/min 73.”
Bentur, L., Hellou, E., Goldbart, A. D., Pillar, G., Monovich, E., Salameh, M., Scherb, I., & Bentur, Y. (2013) · CHEST Journal · doi:10.1378/chest.13-0960 · Cited by 72
Self-citationde Vries, G. E., Wijkstra, P. J., Houwerzijl, E. J., Kerstjens, H. A. M., & Hoekema, A. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.10.004 · Cited by 81
Mandibular advancement splints for the treatment of sleep apnoea syndrome
Sutherland, K., & Cistulli, P. A. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13276 · Cited by 93
The efficacy of oral appliances in the treatment of severe obstructive sleep apnea
LAM, B. K., Sam, K., Lam, J. C. M., Lai, A. Y. K., Lam, C.-L., & Ip, M. (2011) · Sleep And Breathing · doi:10.1007/s11325-011-0496-y · Cited by 72
“Moreover, ejection fraction and endothelial function were found to be improved to near-normal values even though post-OA treatment AHI was still at 20 [28].”
BackgroundImpact of Mandibular Advancement Therapy on Endothelial Function in Severe Obstructive Sleep Apnea
Gagnadoux, F., Pépin, J., Vielle, B., Bironneau, V., Chouet-Girard, F., Launois, S. H., Meslier, N., Meurice, J.-C., Nguyên, X.-L., Paris, A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1817oc · Cited by 72
“A previous study reported a significant increase in RHI after 3 months of MAD therapy in 16 subjects with OSA (34), but this was an uncontrolled study with no sham device group.”
BackgroundMethodInfluentialManiaci, A., Lavalle, S., Parisi, F. M., Barbanti, M., Cocuzza, S. G., Iannella, G., Magliulo, G., Pace, A., Lentini, M., Masiello, E., et al. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11070204 · Cited by 78
“A study by Itzhaki et al. found that MAD treatment significantly decreased urinary norepinephrine levels and improved HRV parameters, indicating a reduction in sympathetic activity [111].”
Gauthier, L., Laberge, L., Beaudry, M., Laforte, M., Rompre, P. H., & Lavigne, G. J. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.05.004 · Cited by 70
“The majority of long-term follow-up studies involving an MAA focus on tooth displacement and/or skeletal changes [6–17].”
BackgroundGozal, D., Etzioni, T., Bhattacharjee, R., Tan, H., Samiei, A., Molero, H., Busool, Y., & Pillar, G. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.02.010 · Cited by 56
“In addition, some of the variance in endothelial function (EF) has been ascribed to circulating endothelial progenitor cells [15], and abnormalities in postocclusive reperfusion responses are reversed when adequate and effective treatment of the underlying OSA syndrome is administered [11,16].”
BackgroundSelf-citationFranco, C. M. R., de Lima, A. M. J., Ataíde, L., Lins, O. G., de Castro, C. M. M. B., Bezerra, A. A., de Oliveira, M. F., & de Oliveira, J. R. M. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9738-0 · Cited by 59
“Moreover, treatment with nCPAP has already been shown to attenuate oxidative stress (Barceló et al. 2000; Carpagnano et al. 2003; Lavie et al. 2004; Itzhaki et al. 2007).”
BackgroundPépin, J., Tamisier, R., Borel, J., Baguet, J.-P., & Levy, P. A. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283318585 · Cited by 57
Balasubramaniam, R., Klasser, G. D., Cistulli, P. A., & Lavigne, G. J. (2014) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.3736 · Cited by 68
Obstructive sleep apnoea – an update
Chan, A. S. L., Phillips, C. L., & Cistulli, P. A. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.02069.x · Cited by 50
Non–Positive Airway Pressure Modalities: Mandibular Advancement Devices/Positional Therapy
Chan, A. S. L., Lee, R. W. W., & Cistulli, P. A. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200707-104mg · Cited by 49
Niżankowska-Jędrzejczyk, A., Almeida, F. R., Lowe, A. A., Kania, A., Nastałek, P., Mejza, F., Foley, J. H., Niżankowska‐Mogilnicka, E., & Undas, A. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.3522 · Cited by 53
“17,18 MAS treatment improved the endothelial function despite the presence of residual apneas.”
History of Dental Sleep Medicine
Rogers, R. R., Remmers, J. E., Lowe, A. A., Cistulli, P. A., Prinsell, J. R., & Pantino, D. A. (2014) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.3744 · Cited by 41
Vanderveken, O. M. (2015) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.4428 · Cited by 40
Biology of peripheral blood cells in obstructive sleep apnea – the tip of the iceberg
Lavie, L., Dyugovskaya, L., & Polyakov, A. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802306701 · Cited by 44
“Moreover, the impact of OSA on endothelial dysfunction is further demonstrated by showing that such early signs of atherosclerosis can be improved after 3 or 4 months of treatment with nCPAP or dental device (Drager et al., 2007; Itzhaki et al., 2007).”
BackgroundSelf-citationGagnadoux, F., Nguyên, X.-L., Vaillant, M. L., Priou, P., Meslier, N., Eberlein, A., Kün‐Darbois, J., Chaufton, C., Villiers, B., Levy, M., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.08.004 · Cited by 48
Cardiovascular consequences of obstructive sleep apnoea.
Kuniyoshi, F. H. S., Pusalavidyasagar, S. S., Singh, P., & Somers, V. K. (2010) · PubMed · Cited by 48
Significance of endothelial dysfunction in sleep‐related breathing disorder
Lui, M. M., Lam, D., & Ip, M. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02212.x · Cited by 40
Effectiveness and Outcome of Oral Appliance Therapy
Pliska, B. T., & Almeida, F. R. (2012) · Dental Clinics of North America · doi:10.1016/j.cden.2012.02.003 · Cited by 40
Joyeux‐Faure, M., Tamisier, R., Baguet, J.-P., Dias-Domingos, S., Perrig, S. H., Lefthériotis, G., Janssens, J.-P., Trzépizur, W., Launois, S. H., Stanke‐Labesque, F., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/423120 · Cited by 42
“The determination of the sample size was based on published data on the beneficial effect of an oral appliance using the same endpoint [28], showing that PAT improved from 1.”
MethodAlmeida, F. R., & Bansback, N. J. (2013) · SLEEP · doi:10.5665/sleep.2938 · Cited by 35
Sleep Medicine Education at Dental Schools in Australia and New Zealand
Balasubramaniam, R., Pullinger, A. G., & Simmons, M. (2014) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.3728 · Cited by 37
Hoffmann, M. S., Singh, P., Wolk, R., Narkiewicz, K., & Somers, V. K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.09.033 · Cited by 34
Effect of oral appliance on endothelial function in sleep apnea
Lin, C.-C., Wang, H., Chiu, C., & Liaw, S. (2014) · Clinical Oral Investigations · doi:10.1007/s00784-014-1234-1 · Cited by 32
“They also showed a significant improvement in ejection fraction with a trend toward correlation between improvement in OSAS severity and in ejection fraction after MAD treatment [24].”
Making Sense of Oxidative Stress in Obstructive Sleep Apnea: Mediator or Distracter?
Zhang, J., & Veasey, S. C. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00179 · Cited by 33
“That therapy fully reverses nitration suggests that OSA itself is a primary contributor to protein nitration.”
BackgroundYu, M., Ma, Y., Han, F., & Gao, X. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292832 · Cited by 39
Galić, T., Božić, J., Pecotić, R., Ivković, N., Valić, M., & Đogaš, Z. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5480 · Cited by 30
“25 An ESS score higher than 10 represented the presence of excessive daytime sleepiness.”
Yamamoto, U., Nishizaka, M., Tsuda, H., Tsutsui, H., & Ando, S. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01392-3 · Cited by 37
Galić, T., Božić, J., Ivković, N., Gunjača, G., Kurir, T. T., & Đogaš, Z. (2015) · Sleep And Breathing · doi:10.1007/s11325-015-1186-y · Cited by 36
“Systolic and diastolic blood pressure slightly decreased but did not reach significant level while cSBP, an independent cardiovascular risk factor [4, 13, 15, 25], decreased almost to the level of significance (123.”
BackgroundInfluentialAlmeida, F. R., Mulgrew, A. T., Ayas, N., Tsuda, H., Lowe, A. A., Fox, N., Harrison, S., & Fleetham, J. A. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2576 · Cited by 30
“28 In a recent study, Lam and collaborators 29 evaluated a group of severe OSA patients with recent diagnosed hypertension or on hypertensive drugs and found that despite the partial reduction in the AHI (67 to 25/h), there was significant improvement in the systolic and diastolic blood pressure…”
Bosshard, V., Masse, J.-F., & Sériès, F. (2011) · Thorax · doi:10.1136/thx.2010.150334 · Cited by 33
ORal Appliance Network on Global Effectiveness (ORANGE): Start-Up and Design Description
Almeida, F. R., Vanderveken, O. M., Cistulli, P. A., Fleury, B., Gagnadoux, F., Hoekema, A., Huynh, N. T., Hwang, D., Kuna, S. T., Kushida, C. A., et al. (2014) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.3730 · Cited by 28
Pau, M. C., Zinellu, E., Fois, S. S., Piras, B., Pintus, G., Carru, C., Mangoni, A. A., Fois, A. G., Zinellu, A., & Pirina, P. (2021) · Antioxidants · doi:10.3390/antiox10071053 · Cited by 30
Lin, C.-C., Wang, H., Liaw, S., Chiu, C., & Lin, M.-W. (2018) · Clinical Oral Investigations · doi:10.1007/s00784-018-2560-5 · Cited by 31
Oral Appliances for Sleep-Disordered Breathing
Cistulli, P. A., Ferguson, K. A., & Lowe, A. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00109-2 · Cited by 28
Uncontrolled type 1 diabetes mellitus and endothelial dysfunction in adolescents.
Shachor‐Meyouhas, Y., Pillar, G., & Shehadeh, N. (2007) · PubMed · Cited by 30
Self-citationPotential therapeutic targets in obstructive sleep apnoea
Saboisky, J. P., Chamberlin, N. L., & Malhotra, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903005608 · Cited by 27
“Oral appliances can lead to some improvements in daytime sleepiness, blood pressure [114] and endothelial function [115].”
Obstructive sleep apnea and its management
Sunitha, C., & Kumar, S. (2010) · Indian Journal of Dental Research · doi:10.4103/0970-9290.62806 · Cited by 28
Sheats, R. D., & Essick, G. (2014) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.3742 · Cited by 24
Cardiovascular Benefits of Oral Appliance Therapy in Obstructive Sleep Apnea: A Systematic Review
Haesendonck, G. V., Dieltjens, M., Kastoer, C., Shivalkar, B., Vrints, C. J., Heyning, C. M. V. D., Braem, M. J. A., & Vanderveken, O. M. (2015) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.4430 · Cited by 29
Mogell, K., Blumenstock, N. T., Mason, E., Rohatgi, R., Shah, S., & SCHWARTZ, D. B. (2019) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.7090 · Cited by 27
Management of Snoring and Obstructive Sleep Apnea with Mandibular Repositioning Appliances
Barewal, R. M., & Hagen, C. C. (2013) · Dental Clinics of North America · doi:10.1016/j.cden.2013.09.010 · Cited by 34
Impact of sleep-disordered breathing treatment on upper airway anatomy and physiology
Shrivastava, D. K. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.01.002 · Cited by 25
“OSA-related oxidative stress and endothelial dysfunction also improve with the use of MAD [67,68].”
BackgroundDefinition of an Effective Oral Appliance for the Treatment of Obstructive Sleep Apnea and Snoring
Scherr, S. C., Dort, L. C., Almeida, F. R., Bennett, K. M., Blumenstock, N. T., Demko, B. G., Essick, G., Katz, S. G., McLornan, P. M., Phillips, K. S., et al. (2014) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.3740 · Cited by 23
Murri, M., Garcia-Delgado, R., Alcázar-Ramírez, J., Linde, F., Fernández-Ramos, A. M., Cardona, F., & Tinahones, F. J. (2010) · PubMed · Cited by 19
Choi, J. H., Yi, J. S., Lee, S. H., Kim, C. S., Kim, T. H., Lee, H. M., LEE, B., Lee, S. H., & Chung, Y. (2011) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2011.00978.x · Cited by 24
“Itzhaki et al. (2007) reported that long-term OA treatment may improve OSAS with cardiovascular risk factors such as endothelial function and oxidative stress markers.”
BackgroundScreening for Sleep Disordered Breathing Among Applicants for a Professional Driver's License
Tzischinsky, O., Cohen, A., Doveh, E., Epstein, R., Ribak, J., Klein, D., Pillar, G., & Lavie, P. (2012) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31825b1bb1 · Cited by 18
Self-citationSivam, S., Witting, P. K., Hoyos, C. M., Maw, A. M., Yee, B. J., Grunstein, R. R., & Phillips, C. L. (2014) · Journal of Sleep Research · doi:10.1111/jsr.12271 · Cited by 18
“In addition, antioxidant protective enzyme paraxonase-1 (Barcelo et al., 2000; Itzhaki et al., 2007; Lavie et al., 2004) and plasma antioxidants (vitamins A, E and gamma-glutamyltransferase levels; Barcelo et al., 2006) have also been assessed as measures of total antioxidant capacity in OSA.”
BackgroundInfluentialObstructive sleep apnoea and cardiovascular disease: a literature review
Assallum, H., Song, T.-Y., Aronow, W. S., & Chandy, D. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.88558 · Cited by 18
“However, prior studies on MAD have shown significant improvement in PAT [111] and equivalent response when MAD was compared to CPAP treatment in patients with OSA [112].”
ResultSingh, G. D., Keropian, B., & Pillar, G. (2009) · CRANIO® · doi:10.1179/crn.2009.017 · Cited by 14
Self-citationGelb, M. L. (2014) · Journal of the California Dental Association · doi:10.1080/19424396.2014.12221401 · Cited by 14
Mandibular advancement splints for the treatment of obstructive sleep apnea
Chan, A. S. L., Sutherland, K., & Cistulli, P. A. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1686978 · Cited by 17
“[53,54], although the studies are few with small numbers of patients.”
BackgroundPulse Wave Analysis During Sleep
Grote, L., & Zou, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00167-7 · Cited by 14
Gupta, A., Tripathi, A., & Sharma, P. (2017) · Sleep And Breathing · doi:10.1007/s11325-017-1534-1 · Cited by 11
Oral Appliance Therapy: A Case of False Negatives
Smith, H. A. (2015) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.4432 · Cited by 9
Lettieri, C. J., Almeida, F. R., Cistulli, P. A., & Carra, M. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00147-1 · Cited by 12
Trenaman, L., Sadatsafavi, M., Almeida, F. R., Ayas, N., Lynd, L. D., Marra, C. A., Stacey, D., & Bansback, N. J. (2014) · Medical Decision Making · doi:10.1177/0272989x14556676 · Cited by 11
Endothelial function in children with a history of henoch schonlein purpura
Aviel, Y. B., Dafna, L., Pillar, G., & Brik, R. (2017) · Pediatric Rheumatology · doi:10.1186/s12969-016-0135-z · Cited by 13
Self-citationMinervini, G., Blasio, M. D., Franco, R., Marrapodi, M. M., Vaienti, B., Cicciù, M., & Ronsivalle, V. (2024) · BMC Oral Health · doi:10.1186/s12903-023-03738-w · Cited by 9
“Also, proper diagnosis and management of TMDs can help minimize symptoms and prevent long-term damage to the TMJ [48–50].”
BackgroundGautier‐Veyret, E., Pépin, J., & Stanke‐Labesque, F. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.006 · Cited by 12
“, 2015) or moderate to severe OSA (Itzhaki et al., 2007; Lin et al., 2015; Trzepizur et al., 2009), but this result was not confirmed in a recent RCT investigating the impact of two months of MAD versus a sham device in severe OSA patients with no overt CVD (n = 75 in each arm)(Gagnadoux et al.”
BackgroundResultOral Appliance Treatment in a Patient with Down Syndrome
Demko, B. G. (2014) · Journal of Dental Sleep Medicine · doi:10.15331/jdsm.3734 · Cited by 9
The Endothelium as a Target in Pediatric OSA
Gozal, D. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00092 · Cited by 9
“Similar findings were also communicated on younger adult patients with OSA who were free of any known cardiovascular involvement, and as previously shown, CPAP treatment resulted in reversal of endothelial dysfunction (Itzhaki and Wertheimer, 1997; Itzhaki et al., 2007).”
ResultTahrani, A. A., & Ali, A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4899-8035-9_9 · Cited by 7
Obstructive Sleep Apnea and Its Management: A Narrative Review
Gomase, V., Deshmukh, P. T., & Lekurwale, V. (2023) · Cureus · doi:10.7759/cureus.37359 · Cited by 16
Geraads, A., d’Athis, P., Lerousseau, L., Larzul, J. J., Bénichou, M., Guyonnaud, C. D., Figueredo, M., Steinbauer, J., Bedicam, J.-M., Martin, F., et al. (2010) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2009.12.014 · Cited by 9
Metadata
- Authors
- Itzhaki, S., Dorchin, H., Clark, G., Lavie, L., Lavie, P., & Pillar, G.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- University of Southern California (US)
- Corresponding author
- Pillar, Giora
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 131
- Issue
- 3
- Pages
- 740-749
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2075459286
- Cited by
- 172
- References
- 52
- Citations by year
- 2026: 1 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 2 · 2019: 6 · 2018: 3 · 2017: 12 · 2016: 5 · 2015: 20 · 2014: 32 · 2013: 11 · 2012: 14
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Dentistry › Orthodontics › Orthodontics and Dentofacial Orthopedics
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Keywords
- obstructive sleep apnea, mandibular advancement device, oxidative stress, endothelial function, malondialdehyde, apnea-hypopnea index, daytime sleepiness, lipid peroxidation, apnea severity, Epworth Sleepiness Scale, TBARS, endothelial dysfunction, sleep-disordered breathing
- MeSH terms
- Adult, Arousal, Endothelium, Vascular, Female, Follow-Up Studies, Humans, Male, Malondialdehyde, Middle Aged, Reference Values, Wakefulness, Lipid Peroxidation, Polysomnography, Orthodontic Appliances, Functional, Thiobarbituric Acid Reactive Substances, Oxidative Stress, Mandibular Advancement, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.